M&A Deal Summary

Sanofi Acquires Symbion CP Holdings Pty

On July 21, 2008, Sanofi acquired consumer products company Symbion CP Holdings Pty from Healius for 560M AUD

Acquisition Highlights
  • This is Sanofi’s 1st transaction in the Consumer Products sector.
  • This is Sanofi’s 12th largest (disclosed) transaction.
  • This is Sanofi’s 1st transaction in Australia.

M&A Deal Summary
Date 2008-07-21
Target Symbion CP Holdings Pty
Sector Consumer Products
Buyer(s) Sanofi
Sellers(s) Healius
Deal Type Divestiture
Deal Value 560M AUD

Target

Symbion CP Holdings Pty

Melbourne, Australia
website
Symbion CP Holdings Pty Ltd. manufactures, markets and distributes nutraceuticals (vitamins & mineral supplements) and over the counter brands throughout Australia and New Zealand. Symbion Consumer has a strong portfolio of premium brands including Natures Own, Cenovis, Bio-organics, Golden Glow and Microgenics.

Search 192,349 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sanofi

Paris, France

website

Category Company
Founded 1994
Sector Life Science
Employees99,412
Revenue 45.4B EUR (2022)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1994 and is based in Paris, France.

DEAL STATS #
Overall 1 of 27
Sector (Consumer Products) 1 of 3
Type (Divestiture) 1 of 3
Country (Australia) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 12 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-01-01 Sylachim S.A.

France

Sylachim S.A. manufactures and distributes fine chemicals and pharmaceutical active ingredients for production of drugs.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-09 Medley Indústria Farmacêutica

Campinas, Brazil

Medley is the third largest pharmaceutical company and the number one generic company in Brazil. The company is the major generic player and the third largest pharmaceutical company in Brazil with a total 5.7% market share and a CAGR - Compound Annual Growth Rate - of 28% over the last 3 years (IMS MAT Feb. 09). The portfolio is composed of 127 products, out of which 17 of the top 20 generics products in the market.

Buy €500M

Seller(S) 1

SELLER

Healius

Sydney, Australia

website

Category Company
Founded 1994
Sector Healthcare Services
Employees11,000
Revenue 2.3B AUD (2022)
DESCRIPTION

Healius is a comprehensive range of services and facilities to general practitioners, specialists and other health care providers who conduct their own practices and businesses at its medical centres, licensed day surgeries, specialist and dental clinics. Primary Health Care centres operate throughout Australia and its formula for medical centres and services offers value to doctors and patients while providing for a relatively low cost of operation. Healius was founded in 1994 and is based in Sydney, Australia.

DEAL STATS #
Overall 1 of 3
Sector (Consumer Products) 1 of 1
Type (Divestiture) 1 of 3
Country (Australia) 1 of 3
Year (2008) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-01 Health Communication Network

St Leonards, Australia

Health Communication Network Ltd. is a provider of clinical and practice management software for clinicians in Australian.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-13 Healthscope - Queensland Pathology Assets

Melbourne, Australia

Healthscope's Queensland Pathology Assets is a provider of pathology services to public hospitals.

Buy -
Mergr

Product

Company

Legal